positive
Recently
Healthcare chain NephroPlus wins SEBI nod for ₹353 crore IPO
NephroPlus gets SEBI clearance for ₹353.
Delhi-based dialysis services provider NephroPlus (Nephrocare Health Services) has received regulatory approval from Securities and Exchange Board of India to launch an IPO worth ₹353.4 crore as a fresh issue, accompanied by an Offer For Sale (OFS) of 1.27 crore shares by existing investors. The company operates over 500 dialysis centres across India, the Philippines, Nepal and Uzbekistan.
Proceeds will fund expansion of clinic network and debt repayment. The listing is expected to boost the healthcare services ecosystem and offer a rare growth-oriented IPO in the market.